European journal of internal medicine
-
Eur. J. Intern. Med. · Dec 2020
Multicenter Study Observational StudyUse of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study.
Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19. ⋯ HCQ use was associated with a 30% lower risk of death in COVID-19 hospitalized patients. Within the limits of an observational study and awaiting results from randomized controlled trials, these data do not discourage the use of HCQ in inpatients with COVID-19.